Agency Information Collection Activities: Proposed Collection; Comment Request, 11051-11052 [2017-03190]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 32 / Friday, February 17, 2017 / Notices
Dated: February 13, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03166 Filed 2–16–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Analytical Tools and Approaches for
(Multidimensional) Scholarly Research
Assessment and Decision Support in the
Biomedical Enterprise (1214).
Date: February 22, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, DHHS, 6001
Executive Blvd., Room 4238, MSC 9550,
Bethesda, MD 20892–9550, 301–827–5819,
gm145a@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:38 Feb 16, 2017
Jkt 241001
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
BILLING CODE 4140–01–P
[FR Doc. 2017–03169 Filed 2–16–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Clinical Trials Review
Committee.
Date: March 7, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Kathy Salaita, SC.D., Chief,
Scientific Review Branch, NIAMS/National
Institutes of Health, 6701 Democracy
Boulevard, Room 818, Bethesda, MD 20892,
Kathy.Salaita@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: February 13, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy
[FR Doc. 2017–03162 Filed 2–16–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
11051
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA—Review of Member
Conflict applications (AA2 & AA3).
Date: March 17, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: February 13, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03161 Filed 2–16–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning the
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
E:\FR\FM\17FEN1.SGM
17FEN1
11052
Federal Register / Vol. 82, No. 32 / Friday, February 17, 2017 / Notices
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Mandatory
Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930–
0158)—Revision
SAMHSA will request OMB approval
for the Federal Drug Testing Custody
and Control Form (CCF) for federal
agency and federally regulated drug
testing programs which must comply
with the HHS Mandatory Guidelines for
Federal Workplace Drug Testing
Programs using Urine (82 FR 7920)
dated January 23, 2017, and OMB
approval for information provided by
test facilities (laboratories and
Instrumented Initial Test Facilities,
IITFs) for the National Laboratory
Certification Program (NLCP).
The CCF is used by all federal
agencies and employers regulated by the
Department of Transportation (DOT)
and the Nuclear Regulatory Commission
(NRC) to document the collection and
chain of custody of urine specimens at
the collection site, for HHS-certified test
facilities to report results, and for
Medical Review Officers (MROs) to
document and report a verified result.
SAMHSA allows the use of the CCF as
a paper or electronic form.
The current OMB-approved CCF has a
May 31, 2017 expiration date. SAMHSA
has resubmitted the CCF with minor
content revisions to the form for OMB
approval. These revisions are:
• Remove the checkbox, the letters
‘‘DOT’’, and hash line in front of Specify
DOT Agency in Step 1: Completed by
collector or employer Representative;
Line D: Specify Testing Authority.
• Addition of four new analytes
(oxycodone, oxymorphone,
hydrocodone, and hydromorphone) in
Step 5A: Primary Specimen Report—
Completed by Test Facility.
• Removal of the analyte
methylenedioxyethylamphetamine
Custody and Control Form: 1
Donor ............................................................................
Collector ........................................................................
Laboratory .....................................................................
IITF ................................................................................
Medical Review Officer .................................................
NLCP Application Form: 2
Laboratory .....................................................................
IITF ................................................................................
Sections B and C—NLCP Inspection Checklist: 3
Laboratory .....................................................................
IITF ................................................................................
Record Keeping:
Laboratory .....................................................................
IITF ................................................................................
Total .......................................................................
mstockstill on DSK3G9T082PROD with NOTICES
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 15 E57B, 5600 Fishers Lane,
Rockville, MD 20857 OR email a copy
to summer.king@samhsa.hhs.gov.
Written comments should be received
by April 18, 2017.
Total number
of responses
[FR Doc. 2017–03190 Filed 2–16–17; 8:45 am]
BILLING CODE 4162–20–P
17:38 Feb 16, 2017
Jkt 241001
5,400,000
5,400,000
5,400,000
0
5,400,000
0.08
0.07
0.05
0
0.05
450,000
360,000
270,000
0
270,000
1
0
1
0
1
0
3
0
3
0
30
0
1
0
30
0
1
0
30
0
30
0
1
0
30
0
250
0
7,500
0
5,400,061
........................
5,400,061
........................
1,357,533
Federal Emergency Management
Agency
[Docket ID FEMA–2008–0010]
Federal Emergency
Management Agency, DHS.
ACTION: Committee management; notice
of open Federal Advisory Committee
Meeting.
AGENCY:
Frm 00053
Annual burden
(hours)
1
1
1
0
1
DEPARTMENT OF HOMELAND
SECURITY
PO 00000
Burden per
response
(hours)
5,400,000
5,400,000
5,400,000
0
5,400,000
Board of Visitors for the National Fire
Academy
Summer King,
Statistician.
VerDate Sep<11>2014
Responses
per
respondent
Number of
respondents
Form/respondent
(MDEA) in Step 5A: Primary Specimen
Report—Completed by Test Facility.
Based upon information from federal
agencies and from DOT concerning their
regulated industries, the number of
respondents has been reduced from a
total of 6.1 million in 2013 to 5.4
million, which reduces the total burden
hours by 188,766.
Laboratories and IITFs seeking HHS
certification under the NLCP must
complete and submit the NLCP
application form. The NLCP application
form has not been revised compared to
the previous form.
Prior to an inspection, an HHScertified laboratory or IITF is required to
submit specific information regarding
its procedures. Collecting this
information prior to an inspection
allows the inspectors to thoroughly
review and understand the testing
procedures before arriving for the onsite
inspection. The NLCP information
checklist has not been revised compared
to the previous form.
The annual total burden estimates for
the CCF, the NLCP application, the
NLCP information checklist, and the
NLCP recordkeeping requirements are
shown in the following table.
Fmt 4703
Sfmt 4703
The Board of Visitors for the
National Fire Academy (Board) will
meet via teleconference on March 16,
2017. The meeting will be open to the
public.
DATES: The meeting will take place on
Thursday, March 16, 2017, from 1:00 to
3:00 p.m. Eastern Daylight Time. Please
note that the meeting may close early if
the Board has completed its business.
ADDRESSES: Members of the public who
wish to participate in the teleconference
should contact Ruth MacPhail as listed
in the FOR FURTHER INFORMATION
CONTACT section by close of business
SUMMARY:
E:\FR\FM\17FEN1.SGM
17FEN1
]]>Agencies
[Federal Register Volume 82, Number 32 (Friday, February 17, 2017)]
[Notices]
[Pages 11051-11052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03190]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning the opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer at (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information
[[Page 11052]]
are necessary for the proper performance of the functions of the
agency, including whether the information shall have practical utility;
(b) the accuracy of the agency's estimate of the burden of the proposed
collection of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Mandatory Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930-0158)--Revision
SAMHSA will request OMB approval for the Federal Drug Testing
Custody and Control Form (CCF) for federal agency and federally
regulated drug testing programs which must comply with the HHS
Mandatory Guidelines for Federal Workplace Drug Testing Programs using
Urine (82 FR 7920) dated January 23, 2017, and OMB approval for
information provided by test facilities (laboratories and Instrumented
Initial Test Facilities, IITFs) for the National Laboratory
Certification Program (NLCP).
The CCF is used by all federal agencies and employers regulated by
the Department of Transportation (DOT) and the Nuclear Regulatory
Commission (NRC) to document the collection and chain of custody of
urine specimens at the collection site, for HHS-certified test
facilities to report results, and for Medical Review Officers (MROs) to
document and report a verified result. SAMHSA allows the use of the CCF
as a paper or electronic form.
The current OMB-approved CCF has a May 31, 2017 expiration date.
SAMHSA has resubmitted the CCF with minor content revisions to the form
for OMB approval. These revisions are:
Remove the checkbox, the letters ``DOT'', and hash line in
front of Specify DOT Agency in Step 1: Completed by collector or
employer Representative; Line D: Specify Testing Authority.
Addition of four new analytes (oxycodone, oxymorphone,
hydrocodone, and hydromorphone) in Step 5A: Primary Specimen Report--
Completed by Test Facility.
Removal of the analyte methylenedioxyethylamphetamine
(MDEA) in Step 5A: Primary Specimen Report--Completed by Test Facility.
Based upon information from federal agencies and from DOT
concerning their regulated industries, the number of respondents has
been reduced from a total of 6.1 million in 2013 to 5.4 million, which
reduces the total burden hours by 188,766.
Laboratories and IITFs seeking HHS certification under the NLCP
must complete and submit the NLCP application form. The NLCP
application form has not been revised compared to the previous form.
Prior to an inspection, an HHS-certified laboratory or IITF is
required to submit specific information regarding its procedures.
Collecting this information prior to an inspection allows the
inspectors to thoroughly review and understand the testing procedures
before arriving for the onsite inspection. The NLCP information
checklist has not been revised compared to the previous form.
The annual total burden estimates for the CCF, the NLCP
application, the NLCP information checklist, and the NLCP recordkeeping
requirements are shown in the following table.
----------------------------------------------------------------------------------------------------------------
Burden per
Form/respondent Number of Responses per Total number response Annual burden
respondents respondent of responses (hours) (hours)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form: \1\
Donor....................... 5,400,000 1 5,400,000 0.08 450,000
Collector................... 5,400,000 1 5,400,000 0.07 360,000
Laboratory.................. 5,400,000 1 5,400,000 0.05 270,000
IITF........................ 0 0 0 0 0
Medical Review Officer...... 5,400,000 1 5,400,000 0.05 270,000
NLCP Application Form: \2\
Laboratory.................. 1 1 1 3 3
IITF........................ 0 0 0 0 0
Sections B and C--NLCP
Inspection Checklist: \3\
Laboratory.................. 30 1 30 1 30
IITF........................ 0 0 0 0 0
Record Keeping:
Laboratory.................. 30 1 30 250 7,500
IITF........................ 0 0 0 0 0
-------------------------------------------------------------------------------
Total................... 5,400,061 .............. 5,400,061 .............. 1,357,533
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 15 E57B, 5600 Fishers Lane, Rockville, MD 20857 OR email a copy to
summer.king@samhsa.hhs.gov. Written comments should be received by
April 18, 2017.
Summer King,
Statistician.
[FR Doc. 2017-03190 Filed 2-16-17; 8:45 am]
BILLING CODE 4162-20-P
